KraneShares MSCI All China Health Care Index ETF(KURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KURE KraneShares MSCI All China Health Care Index ETF

Closed 08-03 16:00:00 EDT

17.08

-0.20

-1.13%

盘后17.09

+0.00+0.00%

19:34 EDT

High17.15	Low17.01	Vol17.62K
Open17.03	D1 Closing17.28	Amplitude0.84%
Mkt Cap98.25M	Tradable Cap98.25M	Total Shares5.75M
T/O300.93K	T/O Rate0.31%	Tradable Shares5.75M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":17.0849,"timestamp":1785787200000,"preClose":17.28,"halted":0,"volume":17617,"hourTrading":{"tag":"盘后","latestPrice":17.085,"preClose":17.0849,"latestTime":"19:34 EDT","volume":8,"amount":136.6793,"timestamp":1785800047538,"change":0.0001,"changeRate":0.000006,"amplitude":0},"delay":0,"changeRate":-0.011290509259259262,"floatShares":5750778,"shares":5750778,"eps":0,"marketStatus":"Closed","change":-0.1951,"latestTime":"08-03 16:00:00 EDT","open":17.03,"high":17.15,"low":17.005,"amount":300932.99502200005,"amplitude":0.008391,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1785830400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":17.28,"sharesOutstanding":4750002,"nav":17.23,"aum":99045786.4,"dividendRate":0.041897,"bidAskSpread":0.008737,"preHourTrading":{"tag":"盘前","latestPrice":17.28,"preClose":17.28,"latestTime":"07:03 EDT","volume":60,"amount":1036.8000000000002,"timestamp":1785755039206,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":17.085,"preClose":17.0849,"latestTime":"19:34 EDT","volume":8,"amount":136.6793,"timestamp":1785800047538,"change":0.0001,"changeRate":0.000006,"amplitude":0},"volumeRatio":0.779327,"impliedVol":0.145,"impliedVolPercentile":0.3506},"requestUrl":"/m/hq/s/KURE/tweets","defaultTab":"tweets","newsList":[{"id":"1178493143","title":"CRO Stocks Surge: Multiple Overseas MNCs and CXO Firms Report Strong Interim Results, Raise Full-Year Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1178493143","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178493143?lang=en_us&edition=fundamental","pubTime":"2026-08-04 11:08","pubTimestamp":1785812902,"startTime":"0","endTime":"0","summary":"Shares of CRO concept stocks are leading gains in Hong Kong trading. As of writing, WUXI APPTEC (02359) has surged 11.05% to HKD 180.9, GENSCRIPT BIO (01548) is up 10.18% to HKD 17.96, ASYMCHEM...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","KCAI","BK1521","LU0516422366.SGD","LU0708995583.HKD","LU1880383366.USD","LU0359201612.USD","LU1794554557.SGD","LU0140636845.USD","BK1583","LU0326950275.SGD","LU0359202008.SGD","VXUS","LU0043850808.USD","LU0039217434.USD","06821","LU0516423174.USD","LU1242518931.SGD","BK4588","LU2242644610.SGD","BK1610","BK4585","LU0051755006.USD","LU0348825331.USD","LU0181495838.USD","LU0823426480.USD","LU0456827905.SGD","02269","LU0516423091.SGD","LU1242518857.USD","LU1720050803.USD","LU0327786744.USD","LU3063872942.SGD","LU0516422952.EUR","02359","SG9999002562.SGD","LU0417516902.SGD","LU0307460666.USD","LU1046422090.SGD","LU0979878070.USD","BK1589","LU0320764599.SGD","LU0572944931.SGD","LU0588546209.SGD","LU0417516738.SGD","LU0348767384.USD","LU2125910500.SGD","LU1688375341.USD","LU0516422440.USD","HK0000320223.HKD","LU0348766576.USD","LU0823426308.USD","LU2045819591.USD","BK1141","CXO","LU2039709279.SGD","BK1576","LU0456846285.SGD","LU0348735423.USD","LU0052750758.USD","WX","BK1191","IE00B0JY6N72.USD","LU0819121731.USD","KURE","LU0856984785.SGD","01548","SG9999002463.SGD","HK0000306685.HKD","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142629620","title":"Hong Kong Market Opens Higher as Pharma and Tech Stocks Lead Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1142629620","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142629620?lang=en_us&edition=fundamental","pubTime":"2026-08-04 09:46","pubTimestamp":1785807965,"startTime":"0","endTime":"0","summary":"Hong Kong's stock market opened with a positive tone on August 4, as the Hang Seng Index climbed 0.31% to 26,090.98 points, while the Hang Seng Tech Index rose 0.30% to 4,890.34 points.The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","LU0417516902.SGD","09115","HSImain","300347","BK1576","LU0823426480.USD","LU0856984785.SGD","MCHmain","KURE","WXXWY","LU0516422440.USD","03308","03088","07226","03033","82800","LU0516423174.USD","LU0516423091.SGD","LU1242518931.SGD","BK1589","LU0348767384.USD","07552","LU1046422090.SGD","LU0456846285.SGD","603259","LU2125910500.SGD","LU0348825331.USD","LU0823426308.USD","LU0051755006.USD","IE00B0JY6N72.USD","SG9999002562.SGD","HTImain","LU0043850808.USD","LU0320764599.SGD","LU0307460666.USD","LU0140636845.USD","LU0572944931.SGD","LU0979878070.USD","06821","BK1610","LU1720050803.USD","LU2039709279.SGD","02837","LU0516422952.EUR","03347","07200","BK1521","BK1533","BK1583","83115","603127","LU1794554557.SGD","513600","LU3063872942.SGD","002821","LU0348735423.USD","LU0417516738.SGD","300308","LU2045819591.USD","LU0588546209.SGD","BK1122","BK1191","02833","03037","BK1249","LU1242518857.USD","LU0359202008.SGD","07300","LU0181495838.USD","02269","03417","LU0326950275.SGD","HSI","03419","BK1149","HSTECH","09088","LU0039217434.USD","03032","LU0516422366.SGD","LU1688375341.USD","BK1141","HHImain","09067","LU0708995583.HKD","SG9999002463.SGD","LU0359201612.USD","LU0819121731.USD","LU0052750758.USD","LU2242644610.SGD","LU0348766576.USD","03115","LU0327786744.USD","06127","03423","07500","LU1880383366.USD","LU0456827905.SGD","03067","02800"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656371972","title":"CSPC Pharma Begins Phase Ib/II Trial of Colorectal Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656371972","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656371972?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:56","pubTimestamp":1785761796,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical  initiated a phase Ib/II clinical trial of the combination therapy of its SYS 6090 Injection at the first research center in China.The drug is being tested for the treatment of colorectal cancer, according to a Monday Hong Kong bourse filing.Pre-clinical study results showed the drug candidate significantly inhibited tumor growth with favorable safety and tolerability.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1807302812.USD","BK1521","LU0501845795.SGD","IE00BZ08YS42.EUR","LU0072913022.USD","LU0880133367.SGD","LU1152091754.HKD","LU1226288253.USD","LU1152091168.USD","LU1226287792.SGD","LU1328277881.USD","IE0008369823.USD","BK1191","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU0140636845.USD","LU0314109678.HKD","LU1951186391.HKD","IE00B543WZ88.USD","LU1813983027.USD","LU1008478684.HKD","IE0008368742.USD","LU1993786604.SGD","IE00BZ08YR35.GBP","SG9999004220.SGD","KURE","BK1515","HK0000165453.HKD","LU1960683339.HKD","IE00BZ08YT58.USD","LU0315179316.USD","LU1226287875.USD","LU0067412154.USD","LU0326950275.SGD","LU2039709279.SGD","LU1226287529.USD","01093","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375141","title":"CSPC Pharmaceutical - Initiates Phase Ib/Ii Trial of Sys 6090 Injection for Colorectal Cancer in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375141","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375141?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:33","pubTimestamp":1785756801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4400SC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1008478684.HKD","LU0315179316.USD","SG9999004220.SGD","LU2039709279.SGD","IE00B543WZ88.USD","LU1226288170.HKD","LU0314109678.HKD","IE0008368742.USD","LU1951186391.HKD","IE00BZ08YT58.USD","LU1152091168.USD","LU1152091754.HKD","LU0880133367.SGD","LU1813983027.USD","LU1226287792.SGD","LU0067412154.USD","LU0140636845.USD","LU1226288253.USD","IE00BZ08YS42.EUR","BK1515","HK0000165453.HKD","BK1521","KURE","IE00B5MMRT66.SGD","LU1807302812.USD","01093","IE00B031HY20.USD","BK1191","LU1960683339.HKD","LU0072913022.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU0501845795.SGD","LU1226287875.USD","LU1328277881.USD","IE0008369823.USD","LU1993786604.SGD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656937496","title":"Akeso (SEHK:9926) Dosed Its First AK138D1 Patient, Is The 47% Undervalued View Too Bullish?","url":"https://stock-news.laohu8.com/highlight/detail?id=2656937496","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656937496?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:20","pubTimestamp":1785756010,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) is back in focus after dosing the first patient in a Phase Ib/II trial of its HER3 antibody drug conjugate AK138D1 for advanced non small cell lung cancer.\nSee our latest analysis for Akeso.\nAkeso’s latest trial milestone comes after a period where sentiment has cooled, with the share price at HK$91.95 and the 1-year total shareholder return down 39.55%, although the 3-year total shareholder return remains very strong.\nIf Akeso’s oncology work has caught your attention, this...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-dosed-its-first-ak138d1-patient-is-the-47-und","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-dosed-its-first-ak138d1-patient-is-the-47-und","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2476274720.SGD","IE00B5MMRT66.SGD","LU0348827113.USD","LU0417516571.SGD","BK1161","LU0348735423.USD","LU0348784397.USD","LU0540923850.HKD","LU0348783233.USD","LU0348825331.USD","LU1794554557.SGD","LU2488822045.USD","IE00BPRC5H50.USD","LU2778985437.USD","LU0348767384.USD","LU1961090484.USD","LU0348766576.USD","LU2399975544.HKD","LU2476274308.USD","LU0417516738.SGD","LU1720050803.USD","KURE","09926","IE00B543WZ88.USD","LU0561508036.HKD","BK1574","LU0417516902.SGD","LU0634319403.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656324885","title":"CSPC Pharmaceutical Group Stock Falls 1.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2656324885","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656324885?lang=en_us&edition=fundamental","pubTime":"2026-08-03 16:33","pubTimestamp":1785745980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. shed 1.3% to 8.47 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 26009.40.CSPC Pharmaceutical Group Ltd. closed 27% short of its 52-week high of HK$11.63, which the company reached Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 1.7%, SSY Group Ltd. rose 2.9%, and United Laboratories International Holdings Ltd. rose 1.4%.Trading volume totaled 52.7 million shares, compared to the 50-day average of 106.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287792.SGD","LU2039709279.SGD","LU1226288170.HKD","IE00B5MMRT66.SGD","LU1807302812.USD","LU0314109678.HKD","IE0008368742.USD","LU1960683339.HKD","LU0072913022.USD","LU0315179316.USD","IE0008369823.USD","LU1152091754.HKD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU0326950275.SGD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1993786604.SGD","BK1521","LU1328277881.USD","KURE","BK1191","BK1515","LU1226288253.USD","LU0501845795.SGD","01093","LU0140636845.USD","SG9999004220.SGD","HK0000165453.HKD","LU0880133367.SGD","LU1226287875.USD","LU1813983027.USD","LU1152091168.USD","LU0067412154.USD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656290233","title":"BeOne Medicines AG Expected to Post Earnings of 15 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656290233","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656290233?lang=en_us&edition=fundamental","pubTime":"2026-08-03 16:02","pubTimestamp":1785744126,"startTime":"0","endTime":"0","summary":"BeOne Medicines AG <6160.HK> expected to post earnings of15cents a share - Earnings PreviewBeOne Medicines AG6160.HKis expected to  report resultson August 5 for the period ending June 30 2026The Basel Basel-stadt-based  company is expected to report revenue of $1.591 billion, according to the estimate from one analyst, based on LSEG data.LSEG's mean analyst estimate for BeOne Medicines AG is for earnings of 15 cents per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 19 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"The average consensus recommendation for the biotechnology & medical research peer group is also \"Buy\".Wall Street's median 12-month price target for BeOne Medicines AG is HK$246.92, about 27.3% above its last closing price of HK$194.00This summary was machine generated August 3 at 08:02 GMT.  All figures in US dollars unless otherwise stated.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4400G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU1770034418.SGD","LU1969619763.USD","LU1251922891.USD","LU2328871848.SGD","LU1303224171.USD","LU0307460666.USD","LU0588546209.SGD","06160","BK1161","BK1588","LU1719994722.HKD","KURE","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656341497","title":"CSPC Pharma Wins China Trial Approval for RSV Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2656341497","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656341497?lang=en_us&edition=fundamental","pubTime":"2026-08-03 09:42","pubTimestamp":1785721373,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical  said China's National Medical Products Administration approved clinical trials for its recombinant respiratory syncytial virus  vaccine candidate, SYS6057, according to a July 31 Hong Kong bourse filing.The vaccine is intended to prevent lower respiratory tract disease caused by RSV in people aged 60 and older","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B543WZ88.USD","LU0501845795.SGD","LU1008478684.HKD","LU1951186391.HKD","LU0140636845.USD","IE00BZ08YT58.USD","BK1521","LU1807302812.USD","IE00BZ08YS42.EUR","LU1226288170.HKD","SG9999004220.SGD","01093","LU1226287529.USD","IE00BZ08YR35.GBP","LU0326950275.SGD","IE00B5MMRT66.SGD","LU1813983027.USD","LU1152091754.HKD","IE0008368742.USD","LU0072913022.USD","LU1993786604.SGD","LU1226288253.USD","IE0008369823.USD","IE00B031HY20.USD","LU1328277881.USD","LU2039709279.SGD","LU1152091168.USD","KURE","LU0314109678.HKD","BK1191","BK1515","HK0000165453.HKD","LU1226287875.USD","LU1226287792.SGD","LU0880133367.SGD","LU1960683339.HKD","LU0315179316.USD","LU0067412154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113503019","title":"CSPC Pharmaceutical Group's SYS6041 Combination Therapy Phase II Trial for Recurrent Ovarian Cancer Has Officially Launched at the First Center in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1113503019","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113503019?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:08","pubTimestamp":1785492493,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that the Phase II clinical trial for its SYS6041 (the product) in combination therapy to treat recurrent ovarian cancer has officially launched at the first center...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1521","IE00BZ08YR35.GBP","LU1226288170.HKD","IE00BZ08YT58.USD","LU0501845795.SGD","SG9999004220.SGD","LU2039709279.SGD","LU0880133367.SGD","LU0067412154.USD","IE00B5MMRT66.SGD","LU1813983027.USD","LU1951186391.HKD","IE0008368742.USD","BMED","LU0072913022.USD","IBBJ","LU1960683339.HKD","BK1191","IE00B543WZ88.USD","LU1226287529.USD","LU1328277881.USD","LU1152091168.USD","LU0314109678.HKD","LU1807302812.USD","PSYK","IE00B031HY20.USD","MDTX","LU1226288253.USD","LU1152091754.HKD","IBBQ","KURE","LU0326950275.SGD","LU0140636845.USD","LU0315179316.USD","LU1226287792.SGD","LU1993786604.SGD","HK0000165453.HKD","IE00BZ08YS42.EUR","LU1226287875.USD","01093","LU1008478684.HKD","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655352559","title":"CSPC Pharma Says China Clears Clinical Trial for RSV Vaccine Candidate SYS 6057","url":"https://stock-news.laohu8.com/highlight/detail?id=2655352559","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655352559?lang=en_us&edition=fundamental","pubTime":"2026-07-31 17:56","pubTimestamp":1785491774,"startTime":"0","endTime":"0","summary":"CSPC Pharma says China clears clinical trial for RSV vaccine candidate SYS 6057CSPC Pharmaceutical received Chinese regulator clearance to start clinical trials of its recombinant RSV vaccine candidat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL10f0d0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1807302812.USD","LU0501845795.SGD","IE00BZ08YT58.USD","LU0067412154.USD","LU0880133367.SGD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU0140636845.USD","LU1008478684.HKD","LU0326950275.SGD","BK1191","BK1521","LU1226288170.HKD","IE00B5MMRT66.SGD","LU1960683339.HKD","SG9999004220.SGD","LU0315179316.USD","01093","LU1813983027.USD","LU1226288253.USD","IE0008369823.USD","LU1226287529.USD","IE00B543WZ88.USD","BK1515","LU0072913022.USD","HK0000165453.HKD","LU1152091754.HKD","IE0008368742.USD","LU1328277881.USD","LU2039709279.SGD","LU1951186391.HKD","LU1226287792.SGD","KURE","LU0314109678.HKD","LU1152091168.USD","LU1226287875.USD","LU1993786604.SGD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655523063","title":"CSPC Pharmaceutical - Pharma's Recombinant Rsv Vaccine (Sys6057) Obtains Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2655523063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655523063?lang=en_us&edition=fundamental","pubTime":"2026-07-31 17:55","pubTimestamp":1785491757,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X0TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01093","LU1008478684.HKD","LU1152091168.USD","IE00BZ08YR35.GBP","LU0072913022.USD","LU1960683339.HKD","IE0008369823.USD","LU0880133367.SGD","BK1521","LU1813983027.USD","LU1152091754.HKD","LU0501845795.SGD","IE00BZ08YT58.USD","LU1226287875.USD","IE00B031HY20.USD","HK0000165453.HKD","IE00B543WZ88.USD","LU1226288170.HKD","LU0314109678.HKD","LU1226287792.SGD","BK1515","LU1807302812.USD","IE00BZ08YS42.EUR","IE0008368742.USD","LU1226287529.USD","LU0326950275.SGD","BK1191","LU0315179316.USD","LU0067412154.USD","LU1993786604.SGD","SG9999004220.SGD","LU2039709279.SGD","KURE","LU1951186391.HKD","LU0140636845.USD","LU1328277881.USD","IE00B5MMRT66.SGD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655356455","title":"Medtide Names Ding Lijun as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2655356455","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655356455?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:35","pubTimestamp":1785486901,"startTime":"0","endTime":"0","summary":"Medtide names Ding Lijun as CFONamed Ding Lijun as chief financial officer effective July 31, 2026; she was CFO of Inventronics (Hangzhou) from Feb 2025 to Jul 2026.Ding previously served as finance v","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL6fMHMp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828474.EUR","LU0502904849.HKD","LU2488822045.USD","BK1589","LU2242644610.SGD","300577","BK1583","LU2328871848.SGD","01801","LU1969619763.USD","LU2097828805.USD","BK0214","BK1161","LU2097828557.USD","LU2097828714.EUR","03880","300582","KURE","BK0247","LU2097828631.EUR","BK1141","HK0000165453.HKD","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655735648","title":"Wuxi Biologics (Cayman) Stock Rallies 2.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2655735648","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655735648?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:32","pubTimestamp":1785486720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. advanced 2.5% to 38.74 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25884.43.Wuxi Biologics  Inc. closed 12% short of its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 25.2 million shares, compared to the 50-day average of 31.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","SG9999002562.SGD","LU0051755006.USD","LU0456846285.SGD","LU0516422440.USD","LU1794554557.SGD","LU0823426308.USD","LU0359201612.USD","LU0708995583.HKD","LU0359202008.SGD","LU1242518931.SGD","LU1720050803.USD","KURE","LU1688375341.USD","LU0516422952.EUR","SG9999002463.SGD","LU2039709279.SGD","LU0856984785.SGD","02269","LU0417516902.SGD","LU0588546209.SGD","BK1610","LU0348825331.USD","BK1589","LU0572944931.SGD","LU0823426480.USD","LU0043850808.USD","LU3063872942.SGD","LU0417516738.SGD","LU0320764599.SGD","LU0456827905.SGD","BK1141","LU0326950275.SGD","BK1521","LU0307460666.USD","LU1880383366.USD","LU0181495838.USD","LU0327786744.USD","IE00B0JY6N72.USD","LU0979878070.USD","LU0039217434.USD","LU0348735423.USD","LU0052750758.USD","LU1242518857.USD","LU0516423174.USD","LU0516423091.SGD","LU0819121731.USD","LU0140636845.USD","LU0516422366.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149808402","title":"Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149808402","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149808402?lang=en_us&edition=fundamental","pubTime":"2026-07-31 13:50","pubTimestamp":1785477023,"startTime":"0","endTime":"0","summary":"Several innovative drug concept stocks showed strength in the afternoon session.As of the latest trading, XTALPI (02228) rose 7.45% to HKD 6.92; GENSCRIPT BIO (01548) climbed 6.4% to HKD 18.3;...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422952.EUR","BK1617","HK0000320223.HKD","BK1576","09995","BK0239","LU3063872942.SGD","LU0516423174.USD","BK1161","LU0516423091.SGD","LU0140636845.USD","LU1242518931.SGD","LU0516422366.SGD","BK1589","01548","LU2148510915.USD","BK1521","SG9999002463.SGD","LU0051755006.USD","02269","IE00B0JY6N72.USD","LU0348735423.USD","SG9999002562.SGD","KCAI","LU0516422440.USD","LU0052750758.USD","LU0326950275.SGD","LU2039709279.SGD","LU0456827905.SGD","LU0417516738.SGD","LU0181495838.USD","LU0043850808.USD","LU1064130708.USD","LU2488822045.USD","LU1880383366.USD","LNGR","LU0823426308.USD","LU0456846285.SGD","BK1574","LU1794554557.SGD","BK1141","159992","LU0417516902.SGD","IBBQ","LU1688375341.USD","LU1969619763.USD","LU0327786744.USD","688331","LU0307460666.USD","LU1064131003.USD","HK0000320264.USD","BK4585","LU2328871848.SGD","LU0320764599.SGD","LU0819121731.USD","BK1583","MEDX","LU0708995583.HKD","LU0823426480.USD","06978","LU0588546209.SGD","02228","LU0572944931.SGD","HK0000306685.HKD","LU0359201612.USD","LU0359202008.SGD","BK4588","LU0039217434.USD","VXUS","KURE","LU0348825331.USD","BK1610","LU0979878070.USD","HK0000306701.USD","LU0856984785.SGD","LU1720050803.USD","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176665682","title":"National Bulk Drug Procurement Round 12 to Begin Bidding in Shanghai","url":"https://stock-news.laohu8.com/highlight/detail?id=1176665682","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176665682?lang=en_us&edition=fundamental","pubTime":"2026-07-31 09:12","pubTimestamp":1785460348,"startTime":"0","endTime":"0","summary":"On July 31st, the 12th round of nationally organized bulk drug procurement will open for bidding in Shanghai, with bidding companies starting to enter the venue and submit quotation materials from...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135680900","title":"China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens","url":"https://stock-news.laohu8.com/highlight/detail?id=1135680900","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135680900?lang=en_us&edition=fundamental","pubTime":"2026-07-31 07:16","pubTimestamp":1785453390,"startTime":"0","endTime":"0","summary":"The Shanghai municipal government released its \"15th Five-Year Plan for Health Development\" on July 30, which includes measures to boost the research and development of innovative drugs and medical...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","LU1770034418.SGD","LU2097828474.EUR","LU0307460666.USD","LU0540923850.HKD","LU0502904849.HKD","LU2488822045.USD","BK1588","BK1589","IE00B5MMRT66.SGD","LU0417516902.SGD","LU0348825331.USD","LU2242644610.SGD","LU0417516738.SGD","BK1500","BK1574","BK4585","KCAI","LU2476274308.USD","BK1583","LU0561508036.HKD","06978","LU2328871848.SGD","LU0348827113.USD","01801","LU1969619763.USD","LU0348767384.USD","IE00B543WZ88.USD","LNGR","LU2097828805.USD","09926","LU2476274720.SGD","BK1161","LU2097828557.USD","BK4588","LU1720050803.USD","LU2097828714.EUR","LU1961090484.USD","IBBQ","LU2778985437.USD","MEDX","159992","LU1251922891.USD","KURE","06160","LU0634319403.HKD","LU2097828631.EUR","VXUS","LU0348766576.USD","LU0588546209.SGD","LU0417516571.SGD","LU1719994722.HKD","LU1794554557.SGD","LU0348735423.USD","LU2399975544.HKD","HK0000165453.HKD","LU0348783233.USD","LU0348784397.USD","09688","LU1303224171.USD","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655887895","title":"CSPC Pharma Ramps up Usd/rmb Hedging with FX Swap, Forwards Totaling USD 344 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655887895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655887895?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:10","pubTimestamp":1785406229,"startTime":"0","endTime":"0","summary":"CSPC Pharma ramps up USD/RMB hedging with FX swap, forwards totaling USD 344 millionCSPC Pharmaceutical set a plan to actively manage USD/RMB exposure via FX hedging in its treasury activities.Strateg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL240Tcm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","LU1008478684.HKD","LU1152091168.USD","IE00BZ08YR35.GBP","LU0072913022.USD","LU1960683339.HKD","IE0008369823.USD","LU0880133367.SGD","BK1521","LU1813983027.USD","LU1152091754.HKD","LU0501845795.SGD","IE00BZ08YT58.USD","LU1226287875.USD","IE00B031HY20.USD","HK0000165453.HKD","IE00B543WZ88.USD","LU1226288170.HKD","LU0314109678.HKD","LU1226287792.SGD","BK1515","LU1807302812.USD","IE00BZ08YS42.EUR","IE0008368742.USD","LU1226287529.USD","LU0326950275.SGD","BK1191","LU0315179316.USD","LU0067412154.USD","LU1993786604.SGD","SG9999004220.SGD","LU2039709279.SGD","KURE","LU1951186391.HKD","LU0140636845.USD","LU1328277881.USD","IE00B5MMRT66.SGD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130711808","title":"Beigene Issues 866,100 New Shares Under Employee Stock Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1130711808","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130711808?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:06","pubTimestamp":1785406019,"startTime":"0","endTime":"0","summary":"Beigene Ltd (HKEX: 06160) has announced a capital increase through the issuance of 866,100 new shares to its wholly-owned subsidiary, BGNC2.This move is authorized under the company's Swiss Articles...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","ONC","KURE","LU1719994722.HKD","LU1303224171.USD","LU1770034418.SGD","BK4585","BK4139","BK1588","06160","BK1161","BK1500","BK4526","BK4588","LU1251922891.USD","BK1583","LU0588546209.SGD","LU2328871848.SGD","688235","LU1969619763.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655782001","title":"CSPC Pharmaceutical - Unit Enters FX Swap and FX Forward Contracts with Icbc Since June 16, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655782001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655782001?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:03","pubTimestamp":1785405839,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W14T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0072913022.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1328277881.USD","LU1152091168.USD","LU1807302812.USD","LU0140636845.USD","IE00B5MMRT66.SGD","LU1226288253.USD","LU0314109678.HKD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1960683339.HKD","LU1008478684.HKD","01093","IE00BZ08YS42.EUR","LU1226287529.USD","IE0008368742.USD","LU1813983027.USD","LU1993786604.SGD","IE0008369823.USD","IE00B031HY20.USD","LU0326950275.SGD","BK1191","IE00BZ08YR35.GBP","BK1521","SG9999004220.SGD","LU0880133367.SGD","LU1226287792.SGD","KURE","LU1226287875.USD","LU0067412154.USD","LU1226288170.HKD","LU0501845795.SGD","LU2039709279.SGD","BK1515","LU0315179316.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655487888","title":"CSPC Pharmaceutical - Zhongqi to Place USD 3.19 Mln Security Deposit for FX Swap Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2655487888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655487888?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:03","pubTimestamp":1785405839,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W14T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0501845795.SGD","LU1226287792.SGD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU2039709279.SGD","LU0326950275.SGD","LU1226288170.HKD","LU1226288253.USD","IE00B5MMRT66.SGD","LU1951186391.HKD","IE0008369823.USD","BK1191","IE00B031HY20.USD","LU1960683339.HKD","KURE","LU0315179316.USD","HK0000165453.HKD","LU0067412154.USD","LU1152091754.HKD","LU1328277881.USD","LU1008478684.HKD","LU0880133367.SGD","LU1226287529.USD","LU1807302812.USD","SG9999004220.SGD","LU0140636845.USD","BK1515","IE0008368742.USD","LU0072913022.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU1152091168.USD","01093","LU1813983027.USD","LU1226287875.USD","BK1521","LU0314109678.HKD","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://kraneshares.com/kure/","stockEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.064},{"period":"3month","weight":-0.0143},{"period":"6month","weight":-0.0243},{"period":"1year","weight":-0.1184},{"period":"ytd","weight":0.0141}],"compareEarnings":[{"period":"1week","weight":0.011},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0366},{"period":"6month","weight":0.0796},{"period":"1year","weight":0.1819},{"period":"ytd","weight":0.0955}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.011813},{"month":2,"riseRate":0.625,"avgChangeRate":0.040467},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.011251},{"month":4,"riseRate":0.555556,"avgChangeRate":0.009997},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.006548},{"month":6,"riseRate":0.555556,"avgChangeRate":0.020849},{"month":7,"riseRate":0.666667,"avgChangeRate":0.022663},{"month":8,"riseRate":0.5,"avgChangeRate":-0.022203},{"month":9,"riseRate":0.5,"avgChangeRate":0.002438},{"month":10,"riseRate":0.5,"avgChangeRate":-0.020874},{"month":11,"riseRate":0.5,"avgChangeRate":0.01787},{"month":12,"riseRate":0.375,"avgChangeRate":-0.04543}],"exchange":"ARCA","name":"KraneShares MSCI All China Health Care Index ETF","nameEN":"KraneShares MSCI All China Health Care Index ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.0","shortVersion":"4.47.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"KraneShares MSCI All China Health Care Index ETF(KURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest KraneShares MSCI All China Health Care Index ETF(KURE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"KraneShares MSCI All China Health Care Index ETF,KURE,KraneShares MSCI All China Health Care Index ETF股票,KraneShares MSCI All China Health Care Index ETF股票老虎,KraneShares MSCI All China Health Care Index ETF股票老虎国际,KraneShares MSCI All China Health Care Index ETF行情,KraneShares MSCI All China Health Care Index ETF股票行情,KraneShares MSCI All China Health Care Index ETF股价,KraneShares MSCI All China Health Care Index ETF股市,KraneShares MSCI All China Health Care Index ETF股票价格,KraneShares MSCI All China Health Care Index ETF股票交易,KraneShares MSCI All China Health Care Index ETF股票购买,KraneShares MSCI All China Health Care Index ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"KraneShares MSCI All China Health Care Index ETF(KURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest KraneShares MSCI All China Health Care Index ETF(KURE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}